Sir, Morning glory with serous macular detachment responds to oral acetazolamide
We report a case of morning glory optic disc with serous macular detachment in the left eye. The patient was treated with oral acetazolamide and followed up for a period of 3 years.
Case report
A 27-year-old lady presented in 2006 with onset of distortion in her left eye. Her visual acuity was 6/36 with a morning glory disc anomaly ( Figure 1 ) and serous macular detachment (Figure 3 ). The central foveal thickness (CFT) was 928 mm in the left eye at baseline. With 1 month of oral slow-release acetazolamide 250 mg (Diamox) twice a day, her visual acuity improved to 6/18 and CFT was reduced to 553 mm. The dosage of acetazolamide was gradually tapered to 62.5 mg once a day over a period of 7 months. Her visual acuity improved to 6/9 in the left eye and CFT reduced Table 1) Rebound serous detachment and recurrence of symptoms appeared on stopping oral acetazolamide. 1 Symptoms of distortion and scotoma recurred. Visual acuity dropped to 6/60 in the left eye and CFT increased to 736 mm. There was no response to topical carbonic anhydrase inhibitors. She was recommenced on oral acetazolamide 125 mg once a day and her visual acuity was stable at 6/24 and CFT was 360 mm in the left eye when last reviewed (Figure 2 ; Table 1 ).
Comment
To the best of our knowledge, treatment of serous retinal detachment in morning glory syndrome 2 with acetazolamide has not been previously reported. Improvement in visual acuity and significant reduction in CFT with a low dose of acetazolamide was observed in this case. Acetazolamide increases the pump activity of the retinal pigment epithelium and this is presumably the mechanism of action in this case. 3, 4 Such cases are difficult to treat surgically. 2, 5 Therefore, this report illustrates a novel alternative management approach. Figure 2 Response of central foveal thickness to oral acetazolamide.
